Literature DB >> 12879009

The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts.

Shoshana Peller1, Jenny Frenkel, Tsvee Lapidot, Joy Kahn, Naomi Rahimi-Levene, Rivka Yona, Lior Nissim, Naomi Goldfinger, Dan J Sherman, Varda Rotter.   

Abstract

The p53 tumor suppressor gene was found to play a role in the differentiation of several tissue types. We report here that p53-dependent apoptosis plays a role in the final stages of physiological differentiation of normoblasts, resulting in nuclear condensation and expulsion without cell death. Blood samples of healthy newborns, cord blood as well as bone marrow, were analysed for apoptosis by TUNEL and p53 expression by immunostaining. While some samples exhibited simultaneously several distinct patterns of apoptosis, such as perinuclear, diffused nuclear or nuclear apoptotic bodies, others presented a single defined pattern. Overexpression of p53 protein was detected in normoblasts exhibiting either perinuclear or diffused nuclear p53, corresponding to the nuclear apoptotic pattern in the same sample. Similar results were also evident with colonies cultivated for 12-14 days in culture. Differentiated erythroid colonies exhibited overexpression of p53 and positive TUNEL staining only in the normoblasts. We further examined the state of caspase 3/7 and observed a decrease of this activated enzyme during erythroid differentiation in culture. This study suggests a novel role for apoptosis in normoblast differentiation where nuclear degradation occurs with a delay in the actual cell death. A pivotal role for the p53-dependent apoptosis in the erythroid lineage development is implied. However, this apoptotic process is not fully executed because of the exhaustion in caspase 3/7 and thus cells are diverted towards final stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879009     DOI: 10.1038/sj.onc.1206541

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  GATA-1 associates with and inhibits p53.

Authors:  Cecelia D Trainor; Caroline Mas; Patrick Archambault; Paola Di Lello; James G Omichinski
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

2.  Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.

Authors:  Sue Haupt; Catherine Mitchell; Vincent Corneille; Jake Shortt; Stephen Fox; Pier Paolo Pandolfi; Mireia Castillo-Martin; Dennis M Bonal; Carlos Cordon-Cardo; Guillermina Lozano; Ygal Haupt
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

Review 3.  Lens fibre cell differentiation and organelle loss: many paths lead to clarity.

Authors:  Michael A Wride
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

4.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.

Authors:  Shilpee Dutt; Anupama Narla; Katherine Lin; Ann Mullally; Nirmalee Abayasekara; Christine Megerdichian; Frederick H Wilson; Treeve Currie; Arati Khanna-Gupta; Nancy Berliner; Jeffery L Kutok; Benjamin L Ebert
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

5.  P53 and beta-catenin activity during estrogen treatment of osteoblasts.

Authors:  Nalini Chandar; Rasleen Saluja; Peter C Lamar; Kevin Kolman; Walter C Prozialeck
Journal:  Cancer Cell Int       Date:  2005-07-29       Impact factor: 5.722

Review 6.  PP2A: The Achilles Heal in MDS with 5q Deletion.

Authors:  David A Sallman; Sheng Wei; Alan List
Journal:  Front Oncol       Date:  2014-09-23       Impact factor: 6.244

7.  Comparative Assessment of Vitamin-B12, Folic Acid and Homocysteine Levels in Relation to p53 Expression in Megaloblastic Anemia.

Authors:  Manish K Yadav; Nandini M Manoli; SubbaRao V Madhunapantula
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

8.  Cholesterol-binding protein TSPO2 coordinates maturation and proliferation of terminally differentiating erythroblasts.

Authors:  Benjaporn Kiatpakdee; Kota Sato; Yayoi Otsuka; Nobuto Arashiki; Yuqi Chen; Takuya Tsumita; Wataru Otsu; Akito Yamamoto; Reo Kawata; Jumpei Yamazaki; Yoshikazu Sugimoto; Kensuke Takada; Narla Mohandas; Mutsumi Inaba
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

9.  Evolutionary conservation of a regulative pathway of erythropoiesis in Poikilothermic vertebrates.

Authors:  Rosa Manca; Monia Delia; Marianna Abate; Silvia Zappavigna; Sergio Papa; Chester Glomski; Alessandra Pica
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

10.  Chk1 haploinsufficiency results in anemia and defective erythropoiesis.

Authors:  Nathan C Boles; Sirisha Peddibhotla; Alice J Chen; Margaret A Goodell; Jeffrey M Rosen
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.